Crinetics Pharmaceuticals Share Price Today
(NASDAQ: CRNX)

Name: Crinetics Pharmaceuticals Share Price Today (NASDAQ: CRNX) - Crinetics Pharmaceuticals Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Crinetics Pharmaceuticals share price is $40.3 & ₹3,491.59 as on 1 Feb 2025, 2.30 'hrs' IST

$40.3

▲

0.04

(0.1%)

Market is closed - opens 8 PM, 03 Feb 2025

View live Crinetics Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Crinetics Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Crinetics Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Crinetics Pharmaceuticals share price movements

Today's Low: $39.76
Today's High: $41.07
$40.30
1.35%
Downside
Day's Volatility :3.2%
Upside
1.87%
52 Weeks Low: $35.51
52 Weeks High: $62.53
$40.30
11.89%
Downside
52 Weeks Volatility :43.21%
Upside
35.55%

Crinetics Pharmaceuticals (CRNX) Returns

Period	Crinetics Pharmaceuticals Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-29.07%	-0.6%	0.0%
6 Months	-17.99%	-2.8%	0.0%
1 Year	8.68%	3.3%	0.0%
3 Years	125.39%	11.6%	-13.7%

Crinetics Pharmaceuticals (CRNX) Key Statistics

in dollars & INR

Previous Close	$40.26
Open	$40.35
Today's High	$41.07
Today's Low	$39.7567
Market Capitalization	$3.7B
Today's Volume	$894.1K
52 Week High	$62.53
52 Week Low	$35.51
Revenue TTM	$1.0M
EBITDA	$-304.5M
Earnings Per Share (EPS)	$-3.7
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-40.26%

How to invest in Crinetics Pharmaceuticals Stock (CRNX) from India?

It is very easy for Indian residents to invest directly in Crinetics Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Crinetics Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Crinetics Pharmaceuticals or CRNX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Crinetics Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Crinetics Pharmaceuticals shares which would translate to 0.021 fractional shares of Crinetics Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Crinetics Pharmaceuticals, in just a few clicks!

Returns in Crinetics Pharmaceuticals (CRNX) for Indian investors in Rupees

The Crinetics Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Crinetics Pharmaceuticals investment value today

Current value as on today

₹1,13,243

Returns

₹13,243

(+13.24%)

Returns from Crinetics Pharmaceuticals Stock

₹8,684 (+8.68%)

Dollar Returns

₹4,559 (+4.56%)

Indian investors sentiment towards Crinetics Pharmaceuticals (CRNX)

-68%

Period: Jan 1, 2025 to Jan 31, 2025. Change in 30 Days versus previous period

Search interest for Crinetics Pharmaceuticals Stock from India on INDmoney has decreased by -68% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Crinetics Pharmaceuticals

BlackRock Inc
7.06%
Vanguard Group Inc
6.78%
Driehaus Capital Management LLC
6.35%
T. Rowe Price Associates, Inc.
5.33%
Wellington Management Company LLP
4.81%
FMR Inc
4.80%

Analyst Recommendation on Crinetics Pharmaceuticals

Buy

90%Buy

10%Hold

0%Sell

Based on 20 Wall street analysts offering stock ratings for Crinetics Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 20 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Crinetics Pharmaceuticals Stock (CRNX)

What analysts predicted

Upside of 87.17%

Target:

$75.43

Current:

$40.30

Insights on Crinetics Pharmaceuticals Stock (Ticker Symbol: CRNX)

Price Movement
In the last 1 month, CRNX stock has moved down by -21.2%
Decreasing Revenue
Revenue is down for the last 2 quarters, 640.0K → 399.0K (in $), with an average decrease of 37.7% per quarter
Decreasing Net Profit
Netprofit is down for the last 9 quarters, -40.39M → -76.82M (in $), with an average decrease of 8.5% per quarter
CRNX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 55.1% return, outperforming this stock by 46.8%
Price to Sales
ForCRNX every $1 of sales, investors are willing to pay $2878.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.4 for every $1 of sales.

Crinetics Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Crinetics Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Crinetics Pharmaceuticals (CRNX) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Crinetics Pharmaceuticals Inc	-21.82%	-17.99%	8.68%	125.39%	84.35%
Biontech Se	7.35%	57.95%	33.59%	-31.3%	308.89%
Regeneron Pharmaceuticals, Inc.	-5.9%	-37.18%	-28.8%	8.05%	97.29%
Vertex Pharmaceuticals Incorporated	13.78%	-3.19%	8.71%	82.07%	100.29%
Alnylam Pharmaceuticals, Inc.	16.13%	2.38%	56.77%	86.78%	136.62%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Crinetics Pharmaceuticals Inc	NA	NA	NA	-3.71	-0.4	-0.24	NA	10.3
Biontech Se	160.8	NA	0.04	-3.32	-0.02	-0.01	NA	79.73
Regeneron Pharmaceuticals, Inc.	16.89	16.89	1.06	44.96	0.17	0.07	NA	272.04
Vertex Pharmaceuticals Incorporated	32.84	NA	1.15	0.49	-0.03	0.12	NA	60.65
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.18	-15.01	-0.03	NA	0.25

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Crinetics Pharmaceuticals Inc	Buy	$3.7B	84.35%	NA	0.0%
Biontech Se	Buy	$29.0B	308.89%	160.8	-15.36%
Regeneron Pharmaceuticals, Inc.	Buy	$75.1B	97.29%	16.89	33.61%
Vertex Pharmaceuticals Incorporated	Buy	$112.9B	100.29%	32.84	-4.51%
Alnylam Pharmaceuticals, Inc.	Buy	$35.7B	136.62%	NA	-15.86%

Crinetics Pharmaceuticals Dividend announcements

Crinetics Pharmaceuticals Earnings
Crinetics Pharmaceuticals’s price-to-earnings ratio stands at None
Read More

About Crinetics Pharmaceuticals

Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's lead product candidate is paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist, which is in Phase 3 trial for the treatment of acromegaly; and Phase 2 trial for treating carcinoid syndrome associated with neuroendocrine tumors. It is also developing CRN04894, an investigational oral nonpeptide product candidate to antagonize the adrenocorticotrophic hormone (ACTH) receptor that has completed a Phase 1 study for the treatment of diseases caused by excess ACTH, including congenital adrenal hyperplasia and Cushing's disease. In addition, the company is developing antagonists of the parathyroid hormone (PTH) receptor for the treatment of primary hyperparathyroidism and humoral hypercalcemia of malignancy, and other diseases of excess PTH; identified investigational orally available somatostatin receptor type 3 targeted nonpeptide agonists for the treatment of autosomal dominant polycystic kidney disease; and developing thyroid-stimulating hormone receptor antagonists for the treatment of graves' disease and thyroid eye disease, as well as Oral GLP-1 and GIP nonpeptides for the treatment of diabetes and obesity. Crinetics Pharmaceuticals, Inc. was incorporated in 2008 and is headquartered in San Diego, California.

Organization	Crinetics Pharmaceuticals
Employees	290
CEO	Dr. R. Scott Struthers Ph.D.
Industry	Health Technology

Management People of Crinetics Pharmaceuticals

Name	Title
Dr. R. Scott Struthers Ph.D.	Founder, President, CEO & Director
Dr. Stephen F. Betz Ph.D.	Founder & Chief Scientific Officer
Mr. Marc J. C. Wilson CPA	Chief Financial Officer
Mr. Jeff E. Knight	Chief Operating Officer
Dr. Alan S. Krasner M.D.	Chief Endocrinologist
Gayathri Diwakar	Head of Investor Relations
Ms. Garlan Adams	General Counsel & Corporate Secretary
Ms. Adriana Cabre M.B.A.	Chief Human Resources Officer
Mr. Kevin Capps	Head of Intellectual Property
Mr. Chris Robillard M.B.A.	Chief Business Officer

Important FAQs about investing in CRNX Stock from India :

What is Crinetics Pharmaceuticals share price today?

Crinetics Pharmaceuticals share price today stands at $40.30, Open: $40.35 ; Previous Close: $40.26 ; High: $41.07 ; Low: $39.76 ; 52 Week High: $62.53 ; 52 Week Low: $35.51.

The stock opens at $40.35, after a previous close of $40.26. The stock reached a daily high of $41.07 and a low of $39.76, with a 52-week high of $62.53 and a 52-week low of $35.51.

Can Indians buy Crinetics Pharmaceuticals shares?

Yes, Indians can invest in the Crinetics Pharmaceuticals (CRNX) from India.

With INDmoney, you can buy Crinetics Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Crinetics Pharmaceuticals at zero transaction cost.

How can I buy Crinetics Pharmaceuticals shares from India?

It is very easy to buy Crinetics Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Crinetics Pharmaceuticals (CRNX) be purchased?

Yes, you can buy fractional shares of Crinetics Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Crinetics Pharmaceuticals stocks?

To start investing in Crinetics Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.